Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zentalis Pharmaceuticals
Biotech
Sanofi snags CMO from BioMarin—Chutes & Ladders
Sanofi snags CMO from BioMarin. Anti-aging outfit lands BioNTech vet. Acadia scoops seasoned dealmaker as business chief.
Darren Incorvaia
,
Zoey Becker
Aug 29, 2025 8:30am
Zentalis lays off 40% to fund registrational trial of WEE1 drug
Jan 29, 2025 4:42am
Flagship-backed biotechs name new leaders—Chutes & Ladders
Nov 15, 2024 8:30am
FDA places hold on Zentalis’ WEE1 drug after two sepsis deaths
Jun 18, 2024 8:21am
FDA's Peter Marks doesn't plan to retire soon—Chutes & Ladders
Aug 4, 2023 9:30am
ASCO: Zentalis ovarian cancer data will take WEE1 to phase 3
May 26, 2023 8:40am
